Hepatitis B and renal failure: prevalence and associated factors in National University Hospital Center of Cotonou

dc.contributor.authorSEHONOU, JEAN
dc.contributor.authorKPOSSOU, ABOUDOU RAÏMY
dc.contributor.authorAMANDA, Taofick Oyétoundé
dc.contributor.authorSOKPON, Comlan N’déhougbèa Martin
dc.contributor.authorVIGNON, KOFFI RODOLPH
dc.contributor.authorVIGAN, JACQUES
dc.date.accessioned2026-06-02T16:06:57Z
dc.date.available2026-06-02T16:06:57Z
dc.date.issued2018
dc.description.abstractIntroduction: the association between the kidneys and hepatitis B is complex. This study aims to determine the prevalence and factors associated with renal disease in people living with hepatitis B virus (PLHBV) in Cotonou. Methods: we conducted a cross-sectional, descriptive and analytical study in the Hepatogastroenterology Department at the National University Hospital Center in Cotonou over the period May -August 2017. All the patients with positive hepatitis B surface antigen (HBS Ag) test hospitalized in the study period were included. The diagnosis of renal failure was retained in patients with glomerular filtration rate less than 90 mL/min/1.73 m2 (estimated with MDRD Equation). Results: the study involved 105 patients with positive hepatitis B surface antigen (HBS Ag) test Among them, 65 (61.9%) were under anti-HBV treatment ( 62 of them were under tenofovir ); 41 patients had renal failure (39%) with tubular involvement (2 cases) and glomerular involvement (4 cases). Renal function had got progressively worse over time in 22 patients (21%) and had improved in 6 patients (5.7%). Univariate analysis showed that factors associated with the occurrence of renal failure were: age greater than 50 years (p = 0.0125), high blood pressure (p = 0.0037), initially abnormal renal function (p < 0.0003) and co-medications (p = 0.0007). Anti-HBV treatment wasn't associated with the occurrence of renal failure (p = 0.2887). Conclusion: the prevalence of renal failure in PLHBV was high (39%). Age, arterial hypertension, pre-existing renal failure and co-medications were identified as factors associated with decline in renal function in PLHBV.
dc.identifier.otherBECDB-8120
dc.identifier.urihttps://dspace.uac.bj/handle/123456789/7300
dc.language.isofr
dc.relation.ispartofPan African Medical Journal
dc.subjectRenal failure
dc.subjecthepatitis B
dc.subjectassociated factors
dc.titleHepatitis B and renal failure: prevalence and associated factors in National University Hospital Center of Cotonou
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
0e58040a200c3dc5c578958876e1ccb0.pdf
Size:
459.24 KB
Format:
Adobe Portable Document Format

Collections